Pfizer - TrumpRx deal boosts Big Pharma to a record rally
Source: SeekingAlpha
2025-10-04 09:59:31 ET
More on Pfizer, VanEck Pharmaceutical ETF, etc.
- Why Eli Lilly Is The Lion's Share Of My Portfolio
- PPH: The Big Pharma ETF
- Pfizer: The Long Suffering Is Finally Over (Rating Upgrade)
- INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag
- Novo’s Wegovy and Lilly’s Zepbound recommended in Europe as first-line obesity treatments
Read the full article on Seeking Alpha
For further details see:
Pfizer – TrumpRx deal boosts Big Pharma to a record rally
VanEck Vectors Pharmaceutical ETF
NASDAQ: PPH
PPH Trading
-0.21% G/L:
$104.72 Last:
252,621 Volume:
$105.19 Open:
